CHSYF
Price
$1.35
Change
-$0.17 (-11.18%)
Updated
Aug 1 closing price
Capitalization
4.27B
SXTC
Price
$1.61
Change
+$0.23 (+16.67%)
Updated
Sep 5 closing price
Capitalization
186.8M
Interact to see
Advertisement

CHSYF vs SXTC

Header iconCHSYF vs SXTC Comparison
Open Charts CHSYF vs SXTCBanner chart's image
China Medical System Holdings
Price$1.35
Change-$0.17 (-11.18%)
Volume$1K
Capitalization4.27B
China SXT Pharmaceuticals
Price$1.61
Change+$0.23 (+16.67%)
Volume$9.33M
Capitalization186.8M
CHSYF vs SXTC Comparison Chart in %
Loading...
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHSYF vs. SXTC commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHSYF is a Hold and SXTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CHSYF: $1.35 vs. SXTC: $1.61)
Brand notoriety: CHSYF and SXTC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CHSYF: 49% vs. SXTC: 3741%
Market capitalization -- CHSYF: $4.27B vs. SXTC: $186.8M
CHSYF [@Pharmaceuticals: Generic] is valued at $4.27B. SXTC’s [@Pharmaceuticals: Generic] market capitalization is $186.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHSYF’s FA Score shows that 1 FA rating(s) are green whileSXTC’s FA Score has 0 green FA rating(s).

  • CHSYF’s FA Score: 1 green, 4 red.
  • SXTC’s FA Score: 0 green, 5 red.
According to our system of comparison, CHSYF is a better buy in the long-term than SXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHSYF’s TA Score shows that 0 TA indicator(s) are bullish while SXTC’s TA Score has 5 bullish TA indicator(s).

  • CHSYF’s TA Score: 0 bullish, 3 bearish.
  • SXTC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SXTC is a better buy in the short-term than CHSYF.

Price Growth

CHSYF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while SXTC (@Pharmaceuticals: Generic) price change was +10.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.27B) has a higher market cap than SXTC($187M). CHSYF has higher P/E ratio than SXTC: CHSYF (14.12) vs SXTC (0.01). CHSYF YTD gains are higher at: 45.052 vs. SXTC (-60.392).
CHSYFSXTCCHSYF / SXTC
Capitalization4.27B187M2,283%
EBITDAN/AN/A-
Gain YTD45.052-60.392-75%
P/E Ratio14.120.01103,381%
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A2.65M-
FUNDAMENTALS RATINGS
CHSYF vs SXTC: Fundamental Ratings
CHSYF
SXTC
OUTLOOK RATING
1..100
5099
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
3997
PRICE GROWTH RATING
1..100
4065
P/E GROWTH RATING
1..100
7888
SEASONALITY SCORE
1..100
1650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHSYF's Valuation (14) in the null industry is significantly better than the same rating for SXTC (80) in the Pharmaceuticals Major industry. This means that CHSYF’s stock grew significantly faster than SXTC’s over the last 12 months.

CHSYF's Profit vs Risk Rating (94) in the null industry is in the same range as SXTC (100) in the Pharmaceuticals Major industry. This means that CHSYF’s stock grew similarly to SXTC’s over the last 12 months.

CHSYF's SMR Rating (39) in the null industry is somewhat better than the same rating for SXTC (97) in the Pharmaceuticals Major industry. This means that CHSYF’s stock grew somewhat faster than SXTC’s over the last 12 months.

CHSYF's Price Growth Rating (40) in the null industry is in the same range as SXTC (65) in the Pharmaceuticals Major industry. This means that CHSYF’s stock grew similarly to SXTC’s over the last 12 months.

CHSYF's P/E Growth Rating (78) in the null industry is in the same range as SXTC (88) in the Pharmaceuticals Major industry. This means that CHSYF’s stock grew similarly to SXTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHSYFSXTC
RSI
ODDS (%)
Bearish Trend 5 days ago
17%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
30%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
9%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
9%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend about 1 month ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
6%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CHSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ETEC23.710.66
+2.86%
iShares Breakthrough Envirtl Sol ETF
QQQP157.162.90
+1.88%
Tradr 2X Long Innovation100 QuarterlyETF
MAGG20.530.12
+0.57%
Madison Aggregate Bond ETF
PTNQ74.26-0.01
-0.02%
Pacer Trendpilot™ 100 ETF
JCE15.74-0.10
-0.63%
Nuveen Core Equity Alpha Fund

CHSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHSYF has been loosely correlated with CNADF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CHSYF jumps, then CNADF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
CNADF - CHSYF
38%
Loosely correlated
N/A
SBFM - CHSYF
30%
Poorly correlated
-5.24%
SXTC - CHSYF
23%
Poorly correlated
+16.67%
TKNO - CHSYF
22%
Poorly correlated
+2.83%
CANN - CHSYF
7%
Poorly correlated
-8.42%
More

SXTC and

Correlation & Price change

A.I.dvisor tells us that SXTC and CPHI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTC and CPHI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTC
1D Price
Change %
SXTC100%
+16.67%
CPHI - SXTC
26%
Poorly correlated
+16.32%
CHSYF - SXTC
23%
Poorly correlated
N/A
YCBD - SXTC
21%
Poorly correlated
+1.44%
BHC - SXTC
21%
Poorly correlated
+1.94%
ESPR - SXTC
21%
Poorly correlated
+5.93%
More